Tüylü Hücreli Lösemisi Olan Bir Hastada Splenektomi ile Başarılı Bir Şekilde Yönetilen Sweet’s Sendromunun Nadir Bir Bulgusu Alışılmışın Dışında Dev Bacak Ülseri

Kaynakça (7)

1. Robak T, Matutes E, Catovsky D, Zinzani PL, Buske C; ESMO Guidelines Committee. Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26(Suppl 5):100-107
2. Paydas S. Sweet’s syndrome: a revisit for hematologists and oncologists. Crit Rev Oncol Hematol 2013;86:85-95
3. Levy RM, Junkins-Hopkins JM, Turchi JJ, James WD. Sweet syndrome as the presenting symptom of relapsed hairy cell leukemia. Arch Dermatol 2002;138:1551-1554
4. Surovy AM, Pelivani N, Hegyi I, Buettiker U, Beltraminelli H, Borradori L. Giant cellulitis-like Sweet syndrome, a new variant of neutrophilic dermatosis. JAMA Dermatol 2013;149:79-83
5. Habermann TM, Rai K. Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses. Leuk Lymphoma 2011;52(Suppl 2):18-20
6. Theodorou GL, Mouzaki A, Tsiftsis D, Apostolopoulou A, Mougiou A, Theodori E, Vagianos C, Karakantza M. Effect of non-operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cells. Clin Exp Immunol 2007;150:429-436
7. Miniello S, Cristallo G, Testini M, Balzanelli MG, Marzaioli R, Venezia P, Lissidini G, Petrozza D, Nacchiero M. Postsplenectomy type-1 hypersensitivity response: a correlation between IL-4 and IgE serum levels. Immunopharmacol Immunotoxicol 2008;30:71-77.